FutureTech II Acquisition Corp.
FutureTech II Acquisition Corp. is a Delaware-incorporated blank check company formed to complete a merger, stock exchange, asset acquisition, or similar business combination. It has no operating business of its own and is focused on identifying and closing a transaction, with the current disclosed target being Longevity Biomedical, Inc.
Tilikausi 2024 · muutos edellisvuodesta
Kehitys 2021–2024
Liiketoiminta
Osuus liikevaihdostaA publicly traded shell company created to raise capital and pursue a future acquisition.
Transaction structuring and closing activities related to a proposed merger or acquisition.
PIPE-style capital commitments and related financing arrangements tied to the transaction.
Management of IPO proceeds held in trust for shareholder redemptions and deal funding.
Asiakkaat
The company does not sell products or services to end customers in the normal operating sense. Its stakeholders are IPO investors, public shareholders, warrant holders, and potential merger counterparties such as Longevity Biomedical, Inc. The business model depends on attracting a suitable target and securing enough financing and shareholder support to complete the transaction.
Invest in the SPAC for redemption rights and potential upside if a business combination closes.
The target, currently disclosed as Longevity Biomedical, Inc., is the core counterparty for the business combination.
Provide private placement capital to support the merger and post-close capitalization.
Hold optionality on the combined company’s equity value after the transaction.
Strategia
The company’s strategy is to complete its announced business combination and secure the financing needed to close it. Recent disclosures show continued work on a PIPE subscription, redemption management, and extension of the business combination deadline, all of which are aimed at preserving deal optionality and closing conditions.
The company has no operating business until a transaction closes, so execution is existential.
The deal depends on sufficient capital at closing and post-close funding credibility.
Listing status affects redemption dynamics, financing access, and merger completion probability.
Maantiede
FutureTech II Acquisition Corp. is incorporated in Delaware and operates as a U.S.-based capital markets vehicle. The available filings do not disclose operating revenue by geography because the company has no commercial operations; its exposure is primarily to U.S. securities markets, Nasdaq listing status, and the location of its merger target and financing counterparties.
Riskit
The main risk is that the company may fail to complete its business combination, which would leave it without an operating business and could force liquidation or value loss. It also faces redemption pressure, listing risk, and financing risk, all of which can reduce the cash available for closing and weaken the attractiveness of the transaction to counterparties.
- Failure to consummate the business combinationVaikutus: KriittinenTodennäköisyys: Korkea
The company is a blank check entity with no operating business, so failure to close would leave it without a commercial platform.
Kohdistuu: Longevity Biomedical merger process
- Redemptions reduce transaction cashVaikutus: KorkeaTodennäköisyys: Korkea
Shareholder redemptions shrink the trust balance and can make the deal harder to finance.
Kohdistuu - Listing and marketability riskVaikutus: KorkeaTodennäköisyys: Korkea
OTC Pink trading or Nasdaq delisting can reduce liquidity, financing access, and merger credibility.
Kohdistuu: Nasdaq listing status and secondary market trading
- Trust account and third-party claim riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen
Claims against the trust account could reduce funds otherwise available for redemption or closing.
Kohdistuu: Trust account protection and creditor claims
Kirjanpito
Harkinnanvaraiset erätPublic shares subject to redemption are typically measured at redemption value, affecting equity and liabilities.
Vaikutus: Accretion to redemption value and balance sheet presentation
The fee is payable only if the business combination closes, so recognition depends on a contingent event.
Vaikutus: Closing-dependent liability and transaction accounting
The company recorded accretion to redemption value in the period, which changes reported equity and net loss.
Vaikutus: Non-cash charge affecting earnings and shareholders' equity
Management must estimate contingent obligations and transaction-related outcomes in a highly judgmental environment.
Vaikutus: Reported liabilities and expenses may change materially
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Future Vision II Acquisition Corp.
FVNNR · Services-Computer Integrated Systems Design
FACT II Acquisition Corp
FACTW · Aircraft Parts & Auxiliary Equipment, NEC
FutureCrest Acquisition Corp.
FCRS · Blank Checks
RF Acquisition Corp Ii
RFAIR · Blank Checks
RF Acquisition Corp II is a blank check company formed to complete a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar…
Concord Acquisition Corp II
CNDAW · Blank Checks
Concord Acquisition Corp II is a U.S.-based special purpose acquisition company (SPAC) formed to complete a merger, share exchange, asset acquisition, or similar business combination.
Inception Growth Acquisition Ltd
Blank Checks
Inception Growth Acquisition Ltd is a U.S.-listed blank check company formed to find and merge with an operating business through a business combination, such…
Päivitetty: 24.9.2026